MedTrace Logo

Efficacy Study of Gene Therapy for The Treatment of Acute LHON Onset Within Three Months

NCT03428178 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-07-29

No results posted yet for this study

Summary

Efficacy Study of Gene Therapy for The Treatment of Acute Leber's Hereditary Optic Neuropathy (LHON) onset within three months

Conditions

  • Acute LHON
  • Onset Within Three Months
  • Onset Between 3 to 6 Months
  • Onset Between 6 to 12 Months
  • Onset Between 12 to 24 Months
  • Onset Between 24 to 60 Months
  • Onset Over 60 Months

Interventions

DRUG

rAAV2-ND4

rAAV2-ND4 of vitreous cavity injection

Sponsors & Collaborators

  • Bin Li

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-08
Primary Completion
2018-12-06
Completion
2020-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03428178 on ClinicalTrials.gov